Cardiovascular &
Circulatory System
Restoring flow. preserving vitality.
The cardiovascular system sustains every function in the body. When circulation declines — through inflammation, endothelial damage, or structural disease — tissues receive less oxygen, organs lose efficiency, and long-term resilience is compromised across all systems.
At Blast Institute, we approach cardiovascular health as an integrated network — from the heart to the smallest capillaries — guided by regenerative signals that restore flow, repair tissue, and support long-term vascular integrity.
What Drives Cardiovascular Dysfunction
Endothelial Dysfunction
Damage to the inner lining of blood vessels impairs nitric oxide production, increases vascular stiffness, and initiates the inflammatory cascade underlying most cardiovascular disease.
Chronic Vascular Inflammation
Persistent low-grade inflammation drives plaque formation, arterial remodeling, and progressive narrowing — sustaining disease even when acute events are managed.
Microvascular Insufficiency
Impaired capillary function and reduced pericyte-endothelial coupling reduce oxygen delivery to tissues — a key driver of heart failure with preserved ejection fraction (HFpEF) and diabetic cardiomyopathy.
Structural Tissue Damage
Cardiac fibrosis, post-infarct scarring, and progressive loss of myocardial cells reduce pump function and limit the heart’s capacity for self-repair.
The Regenerative Technology Platform
PSC
Pluripotent Stem Cells
Cardiomyogenic factors – Anti-fibrotic – eNOS activation – Immunomodulation
Carry exosomal cargo relevant to all three germ layers, including cardiomyogenic factors, vascular stabilization signals, and immunomodulatory mediators. Adaptive signaling supports cardiac repair, reduces post-ischemic fibrosis, and restores endothelial function through mechanisms unavailable to lineage-restricted preparations.
EXOSOMAL
Pluripotent Exosomes
Pro-angiogenic – Anti-inflammatory – miRNA modulation -Microvascular repair
Highly concentrated vesicles carrying pro-angiogenic signals, anti-inflammatory mediators, and microRNAs that modulate vascular gene expression. Promote formation of new capillaries, reduce oxidative stress in vascular tissue, and enhance intercellular communication within the cardiac and vascular environment.
GENE THERAPY
Klotho Minicircle Therapy
Anti-calcification -Arterial integrity – Endothelial protection – 8–14 month effect
A longevity-associated protein with well-documented cardiovascular protective effects, delivered via non-viral minicircle DNA for sustained expression. Supports arterial integrity, reduces vascular calcification, maintains endothelial function, and protects against age-driven vascular stiffening. Effect duration: 8–14 months.
GENE THERAPY
VEGF-A Minicircle Therapy
Therapeutic angiogenesis -Ischemic tissue rescue -Capillary regeneration – 8–14 month effect
The primary driver of therapeutic angiogenesis — controlled formation of new blood vessels to restore perfusion in ischemic or underperfused tissue. Delivered via minicircle DNA for defined, sustained expression without the risks of uncontrolled vascular growth. Effect duration: 8–14 months.
In development:
LAV-BPIFB4 gene therapy
A vascular rejuvenation gene derived from human longevity biology, LAV-BPIFB4 targets the full spectrum of cardiovascular aging — endothelial function, microvascular integrity, macrophage polarization, and anti-fibrotic remodeling. Expected to be available as part of the cardiovascular program in a future phase.
How the Protocol Works
Terrain preparation
Vascular inflammation and oxidative burden impair the penetration of regenerative signals. Ozone apheresis and IV antioxidant protocols reduce systemic inflammatory load prior to and during treatment — preparing the vascular environment for signaling to work.
Pulsed daily infusions
Each session introduces a fresh wave of cardiovascular-targeted regenerative signals. The adaptive nature of PSC exosomal output means each infusion is calibrated to the patient's evolving physiological state — building progressively on the sessions before it.
Gene therapy extension (optional)
Where indicated, a single administration of Klotho or VEGF-A minicircle therapy at program completion extends the vascular benefit for 8 to 14 months — sustaining endothelial support, angiogenesis, and anti-calcification signaling after the patient returns home.
Progressive vascular recovery
Cardiovascular repair — particularly in chronic and age-related presentations — unfolds over months. Measurable improvements in perfusion, exercise tolerance, and cardiac function develop progressively as cellular integration deepens and new vascular architecture matures.
Conditions We Address
Heart Functions
Ischemic heart disease
Coronary · Perfusion · Chronic
Post-myocardial infarction recovery
Acute · Fibrosis · Remodeling
Heart failure & HFpEF
Microvascular · Diastolic · Function
Vascular Health
Vascular insufficiency
Peripheral · Arterial · Circulation
Endothelial dysfunction
Nitric oxide · Arterial · Systemic
Age-related vascular decline
Longevity · Stiffness · Calcification
Microvascular Applications
Diabetic cardiomyopathy
Metabolic · Microvascular · CXCR4
Scalp revascularization
Hair · Microcirculation · Follicle support
From the heart to the smallest capillary — the entire vascular network is within reach of regenerative signaling. At Blast Institute, we design protocols that address cardiovascular dysfunction at its biological roots, restoring the flow and structural integrity on which every other system depends.